LIPLASOME PHARMA ApS: Financial statements 2016
CVR: 29428514
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
LIPLASOME PHARMA ApS (CVR 29428514) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -328,000 and a net result of DKK -309,000 compared with DKK -2,491,000 the year before. Equity in the 2016 report amounted to DKK 33,893,000. The solvency ratio was 88.7%.
- Gross Profit
- DKK -328,000
- Profit/Loss
- DKK -309,000
- Equity
- DKK 33,893,000
- Total Assets
- DKK 38,190,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -328 t. | -309 t. | 33.9 mio. | 0 |
| 2015 | - | -1.7 mio. | -2.5 mio. | 34.2 mio. | 2 |
| 2014 | - | -1.5 mio. | -2.4 mio. | 31.8 mio. | 2 |
| 2013 | - | -1.2 mio. | -147 t. | 34.2 mio. | 2 |
| 2012 | - | -850 t. | -3 mio. | 19.7 mio. | 2 |
Official annual report
Find more companies like LIPLASOME PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
LIPLASOME PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -1,723,000, and the net result was DKK -2,491,000.
As of February 15, 2016, Sanjay Kumar Sehgal has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Peter Buhl has left the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Duncan Moore has left the board of directors of LIPLASOME PHARMA ApS.
About LIPLASOME PHARMA ApS
LIPLASOME PHARMA ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Horsted Eriksen. The board consists of John Riis Mortensen (chair), Hans-Henrik Horsted Eriksen and Sanjay Kumar Sehgal. The company is owned by BAGGER-SØRENSEN & CO. A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -28,000 and a net result of DKK 62,000 compared with DKK -36,000 the year before. Equity in the 2025 report amounted to DKK 2,377,000.